Relative Bioavailability Study in Healthy Subjects Comparing 2 Dry Powder Oral Suspensions of Rivaroxaban Under Fasting and 20 mg of an Oral Suspension of Rivaroxaban Under Fed Conditions to 10 mg of an Immediate Release Tablet Under Fasting Conditions
Clinical trial NCT02367027 · COMPLETED
Trial details
- NCT number
- NCT02367027
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2015-04-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.